Advancing Sustainable Solid-Phase Peptide Synthesis: The Role of 1‑(3-(Dimethylamino)propyl)-3-ethylcarbodiimide Methotosylate (EDC·MeTos) in Green Solvents Authors: Maria Carmina Scala, Martina Landi, Giovanni Vivenzio, Pietro Campiglia, Marina Sala Published: 2026 ABSTRACT Carbodiimides are essential reagents in peptide synthesis due to their ability to activate carboxylic acids toward amide bond formation. In this study, we investigated the coupling efficiency and racemization propensity of 1-(3-(Dimethylamino)­propyl)-3-ethylcarbodiimide methotosylate (EDC·MeTos), both alone and in combination with ethyl 2-cyano-2-(hydroxyimino)­acetate (OxymaPure), under green solvent conditions as alternatives to the conventional use of N,N-dimethylformamide (DMF). Using Fmoc-based solid-phase peptide synthesis (SPPS), we synthesized several model peptides to assess the coupling efficiency, side-product formation, and epimerization levels across different reaction media. Our results demonstrate that the binary green solvent system EtOAc/DMSO (ethyl acetate/dimethyl sulfoxide, 9:1) supports highly efficient peptide couplings when used with quaternary carbodiimides (QCD), producing peptides of comparable purity to those synthesized in DMF. Remarkably, the use of QCD alone in this green medium led to lower racemization levels than in DMF, highlighting a dual advantage in terms of both environmental impact and stereochemical integrity. The additive OxymaPure was beneficial for sterically hindered sequences such as Aib-ACP (α-aminoisobutyric acid-ACP), but not essential for less demanding peptides. Overall, the findings support the viability of green solvent systems in high-fidelity peptide synthesis, enabling more sustainable manufacturing practices. Introduction Carbodiimides in Peptide Synthesis: Reactivity, Mechanism, and toward Greener Approaches Carbodiimides are a class of organic compounds characterized by the presence of the functional group R–NCN–R′. They play a crucial role in various chemical reactions, particularly in the field of biochemistry and polymer science. Carbodiimides are versatile reagents widely used in organic synthesis as they activate carboxylic acids by forming an O-acylisourea intermediate, which can then react with amines to form amides. , This mechanism underpins both solution- and solid-phase peptide synthesis (SPPS), the latter being the predominant methodology for preparing peptides with high efficiency and purity. − Carbodiimides are widely employed as coupling agents to form amide bonds, with different reagents offering specific reactivity and handling advantages. − Dicyclohexylcarbodiimide (DCC, Figure ) is one of the earliest and most established coupling agents, known for its strong activation ability. However, its use generates dicyclohexylurea (DCU) as a byproduct, which is poorly soluble and difficult to remove from the final product. To address such issues, N,N′-Diisopropylcarbodiimide (DIC, Figure ) was introduced as a more soluble alternative, offering improved handling and lower side-product formation, especially when combined with additives like OxymaPure or hydroxybenzotriazole (HOBt) to reduce racemization and improve coupling efficiency. − Most commonly employed carbodiimide coupling reagents in peptide synthesis. Indeed, additive-based coupling strategies, commonly referred to as the active ester approach, have become an essential component of modern peptide synthesis protocols. In this context, additives such as HOBt, 1-Hydroxy-7-azabenzotriazole (HOAt), and more recently OxymaPure (ethyl 2-cyano-2-(hydroxyimino)­acetate) play a dual role by rapidly intercepting the O-acylisourea intermediate to generate a more stable and highly reactive active ester, while simultaneously suppressing racemization via minimization of oxazolone formation. The combination of carbodiimides such as DIC with these additives has proven particularly effective, offering enhanced coupling efficiency and improved stereochemical control. Among these additives, OxymaPure has emerged as a particularly attractive option due to its favorable safety profile compared to benzotriazole-based additives, reduced explosion hazard, high solubility, and excellent performance in both solution- and solid-phase peptide synthesis. Recent developments have highlighted the potential of TBEC (tert-butyl ethylcarbodiimide, Figure ) as a next-generation coupling reagent in peptide synthesis. Owing to its bulky alkyl substituents, TBEC is designed to minimize side reactions, particularly epimerization, and to enhance reactivity in challenging coupling environments. Importantly, recent studies have validated TBEC as a DMF-free carbodiimide, capable of enabling the efficient synthesis of complex peptides, including liraglutide, under more sustainable conditions while maintaining yields and stereochemical integrity comparable to traditional coupling systems. − 1-Ethyl-3-(3-(dimethylamino)­propyl)­carbodiimide (EDC) represents another important development in this reagent class. Particularly effective in aqueous media, EDC does not produce insoluble byproducts like DCC and is commonly used in bioconjugation and pharmaceutical applications. When combined with N-hydroxysuccinimide (NHS), EDC forms stable active esters, improving coupling efficiency and selectivity. , A more recent and increasingly popular derivative is EDC·MeTos (Figure ), a quaternary carbodiimide salt. The tosylate counterion enhances both solubility and reactivity in organic and aqueous media, making EDC·MeTos a robust and versatile coupling reagent in modern synthetic chemistry. Recent studies have demonstrated that QCD such as EDC·MeTos and 1-(3-(dimethylamino)­propyl)-3-ethylcarbodiimide methiodide (EDC·MeI) avoid the intramolecular cyclization observed in conventional N-ethyl-N′-(3-(dimethylamino)­propyl)­carbodiimide hydrochloride (EDC·HCl, Figure ), exhibit improved solubility, stability over several weeks, and comparable or even reduced epimerization in peptide couplings. While not explicitly classified as green reagents, these salts align with the principles of green chemistry, combining high reactivity with milder conditions and compatibility with green solvents. In parallel, new reactive deep eutectic solvent (DES) systems have been explored as greener media for EDC-mediated amide formation, providing both activation and solvent functionality while significantly reducing environmental impact. , Despite these advances, most carbodiimide-mediated couplings are still performed in conventional solvents such as DMF, which poses significant environmental and safety concerns due to its toxicity and poor biodegradability. − The development of sustainable peptide synthesis protocols, including the use of green solvent mixtures and efficient coupling agents such as QCD, has therefore become a key priority in the broader context of green chemistry and pharmaceutical manufacturing. − In this work, we explore the efficiency, selectivity, and stereochemical integrity of QCD-mediated peptide couplings in green solvent systems, particularly focusing on EtOAc:DMSO (9:1) as a sustainable alternative to DMF. By evaluating EDC·MeTos both alone and in combination with OxymaPure, we aim to assess its performance in synthesizing model peptides of varying complexity, including sterically hindered and epimerization-prone sequences. Our goal is to demonstrate the viability of greener protocols in peptide synthesis without compromising yield or purity. Results and Discussion In this work, we systematically evaluated the performance of quaternary carbodiimide (QCD)-mediated coupling under various solvent conditions, including both traditional and greener alternatives. Our goal was to identify reaction media that not only support high coupling efficiency and selectivity but also minimize racemization and environmental impact. We focused first on the model pentapeptide Leu-enkephalin, chosen for its balanced complexity and well-characterized synthesis, with the intention of benchmarking performance across different solvent and additive combinations. Synthesis of Model Peptides Leu-enkephalin (H-Tyr-Gly-Gly-Phe-Leu-NH2) was selected as a model pentapeptide and synthesized manually using Fmoc-based SPPS on a Rink amide resin. Couplings were performed using 5 equiv of Fmoc-protected amino acid with quaternary carbodiimide (QCD) as the coupling reagent, both with and without OxymaPure as an additive. Various solvents were tested, including the conventional DMF, as reference, and alternative green solvent systems such as EtOAc/DMSO, NOP/DMC (N-octyl-2-pyrrolidone/Dimethyl carbonate, 8:2), and An/NOP (Anisole/NOP, 75:25). As summarized in Table , the coupling systems EDC·MeTos/Oxyma and EDC·MeTos alone in DMF (Entries 1–2) and EtOAc/DMSO (Entries 3–4) exhibited excellent performance, affording the target peptide with high purities (>99% and ∼96.8%, respectively) and minimal side products (Figure ). Chromatographic profile of H-YGGFL-NH2 synthesized with EDC·MeTos/Oxyma and EDC·MeTos in the environmentally friendly solvent, EtOAc/DMSO. 1HPLC Purity of H-YGGFL-NH2 Pentapeptide Synthesized with Different Coupling Agents and Solvents Entry Coupling agent Solvent Purity (%) Des-Phe (%) Des-Gly (%) Des-Leu (%) Others (%) 1 EDC·MeTos/OxymaDMF>99---- 2 EDC·MeTosDMF99.430.57--- 3 EDC·MeTos/OxymaEtOAc/DMSO (9:1)96.90---3.10 4 EDC·MeTosEtOAc/DMSO (9:1)96.70---3.30 5 EDC·MeTos/OxymaNOP/DMC (8:2)4.93--0.8294.25 6 EDC·MeTosNOP/DMC (8:2)61.9--5.9732.13 7 EDC·MeTos/OxymaAn/NOP (75:25)57.40--34.907.70 8 EDC·MeTosAn/NOP (75:25)35.454.8312.30-47.42a(Des = deletion products). HPLC Purity of H-YGGFL-NH2 Pentapeptide Synthesized with Different Coupling Agents and Solvents (Des = deletion products). In contrast, coupling efficiency decreased substantially in greener solvent systems NOP/DMC (8:2), in the presence of Oxyma, whereas in An/NOP (75:25) (Entries 5–8) a similar decrease was observed only in the absence of Oxyma. The data demonstrates that the choice of solvent and the presence of an additive like Oxyma significantly influence the efficiency and selectivity of peptide coupling reactions mediated by quaternary carbodiimide (QCD). DMF (entries 1–2) provided the highest coupling efficiency, with purities exceeding 99%. The addition of Oxyma (Entry 1) led to complete suppression of deletion side-products, while EDC·MeTos alone (Entry 2) resulted in a minor amount of des-phenylalanine (0.57%). These results confirm DMF as a highly effective solvent for QCD-mediated peptide coupling and highlight the beneficial role of Oxyma in enhancing coupling fidelity. EtOAc/DMSO (9:1) (entries 3–4) also showed good performance, with purities around 96.7–96.9%, both with and without Oxyma. This suggests that the EtOAc/DMSO mixture can serve as a viable alternative to DMF, especially when more environmentally benign solvents are desired. However, the slightly reduced purity compared to DMF indicates a modest trade-off in coupling efficiency. In contrast, NOP/DMC (8:2) and An/NOP (75:25) mixtures (Entries 5–8) led to significant losses in product purity, particularly in the absence of Oxyma. In Entry 6 (EDC·MeTos in NOP/DMC), the product purity dropped to 61.9%, with 5.97% des-leucine formation. Entry 5, which included Oxyma, showed extremely low purity (4.93%), suggesting incompatibility of this solvent system with Oxyma or instability of the coupling intermediate. Similarly, entries 7–8, using An/NOP mixtures, resulted in low purities (57.4% and 35.45%, respectively), and considerable levels of deletion products, particularly des-leucine (34.9%) and des-glycine (12.3%). These findings highlight that while Oxyma generally enhances coupling efficiency and suppresses side reactions, its effectiveness is highly solvent-dependent. Polar aprotic solvents like DMF and EtOAc/DMSO support efficient coupling, whereas mixtures involving NOP significantly compromise reactivity and selectivity. To rationalize the observed solvent-dependent behavior, it is important to consider the physicochemical properties of the tested media and their influence on carbodiimide-mediated activation. The efficiency of QCD-mediated coupling is strongly affected by the stabilization of reactive intermediates, particularly the O-acylisourea species and the corresponding Oxyma-derived active ester. In particular, the EtOAc/DMSO (9:1) mixture likely provides an optimal balance between polarity, solvation capability, and solid-phase compatibility. DMSO, as a highly polar aprotic solvent, enhances the solvation of reagents and reactive intermediates, improving the stabilization of charged species formed during activation, while EtOAc contributes to reduced viscosity and improved resin swelling, facilitating mass transfer within the solid support. This synergistic combination promotes efficient diffusion of reagents and supports the formation and stabilization of activated species such as O-acylisourea intermediates and Oxyma-derived active esters, in agreement with previous reports highlighting the importance of polarity and viscosity in green solvent mixtures for SPPS. Moreover, the interplay between solvent polarity and hydrogen-bonding capability may contribute to the suppression of side reactions, such as oxazolone formation, which is a key intermediate in racemization pathways during peptide coupling. , This effect may help explain the comparable or slightly improved stereochemical outcomes observed in EtOAc/DMSO relative to DMF. In contrast, solvent systems such as NOP/DMC and An/NOP may not provide sufficient stabilization of reactive intermediates or may negatively affect resin swelling and reagent accessibility. Additionally, differences in steric environment and solvent–solute interactions may further limit the efficiency of these systems. Overall, these observations highlight that solvent performance in SPPS cannot be rationalized solely on the basis of polarity, but rather depends on a complex interplay of solvation, viscosity, hydrogen-bonding properties, and solid-phase compatibility. Racemization Studies Racemization experiments were conducted using the model tripeptides H-GCF-NH2, H-GSF-NH2, and H-GHF-NH2 to evaluate the extent of epimerization under different coupling conditions, since cysteine, serine, and histidine are amino acids known to be susceptible to racemization during peptide bond formation. , The solvent system EtOAc/DMSO (9:1) was selected on the basis of previous optimization studies aimed at identifying greener alternatives to traditional solvents such as DMF. Couplings were carried out by SPPS using a preactivation protocol with EDC·MeTos as the coupling reagent, either in the presence or absence of OxymaPure. To accurately determine the degree of racemization, both the L- and D-epimers of the peptides were independently synthesized and analyzed by HPLC in order to establish reliable retention time references. The results summarized in Table reveal a clear solvent-dependent effect on racemization. Tripeptides synthesized using the green solvent mixture exhibited significantly lower racemization levels compared to those synthesized in DMF. 2Racemization Studies on H-GCF-NH2, H-GSF-NH2, H-GHF-NH2 in SPPS Entry Peptide Coupling agent Solvent DL (%) 1 H-Gly-Cys- Phe-NH2 EDC·MeTos/OxymaDMF0.98 2 EDC·MeTosDMF2.68 3 EDC·MeTos/OxymaEtOAc/DMSO (9:1)0.90 4 EDC·MeTosEtOAc/DMSO (9:1)0.68 5 H-Gly-Ser- Phe-NH2 EDC·MeTos/OxymaDMFn.d. 6 EDC·MeTosDMFn.d. 7 EDC·MeTos/OxymaEtOAc/DMSO (9:1)n.d. 8 EDC·MeTosEtOAc/DMSO (9:1)n.d. 9 H-Gly-His- Phe-NH2 EDC·MeTos/OxymaDMF5.37 10 EDC·MeTosDMF1.07 11 EDC·MeTos/OxymaEtOAc/DMSO (9:1)0.29 12 EDC·MeTosEtOAc/DMSO (9:1)n.d.aRacemization ratios were determined by HPLC.bDefined as (H-Phe-D-XX-Gly-NH2)/(H-Phe-L-XX-Gly-NH2) × 100. XX = Cys, His, Ser. n.d. = not detected. Racemization Studies on H-GCF-NH2, H-GSF-NH2, H-GHF-NH2 in SPPS Racemization ratios were determined by HPLC. Defined as (H-Phe-D-XX-Gly-NH2)/(H-Phe-L-XX-Gly-NH2) × 100. XX = Cys, His, Ser. n.d. = not detected. For the cysteine-containing tripeptide H-GCF-NH2 (entries 1–4), the lowest racemization value (0.68%) was observed when EDC·MeTos was used alone in EtOAc/DMSO (9:1). Although the absolute differences relative to DMF are modest, the data consistently indicate that the green solvent system preserves, and in some cases slightly improves, stereochemical integrity. To broaden the scope of the study, additional racemization experiments were performed using the model tripeptides H-GSF-NH2 and H-GHF-NH2, containing serine and histidine residues, respectively, both of which may undergo epimerization under coupling conditions. For the serine-containing tripeptide H-GSF-NH2 (entries 5–8), no detectable racemization was observed under any of the tested conditions, either in DMF or in EtOAc/DMSO (9:1), regardless of the presence of OxymaPure. These results demonstrate that EDC·MeTos promotes efficient coupling of serine residues while fully preserving stereochemical integrity. More pronounced differences were observed for the histidine-containing tripeptide H-GHF-NH2 (entries 9–12), since histidine is widely recognized as one of the most racemization-sensitive amino acids in peptide synthesis. In DMF, the use of EDC·MeTos/Oxyma resulted in a relatively high racemization level (5.37%), whereas EDC·MeTos alone significantly reduced epimerization to 1.07%. Notably, the greener EtOAc/DMSO (9:1) solvent system further improved stereochemical outcomes, affording only 0.29% racemization in the presence of OxymaPure, while no detectable racemization was observed when EDC·MeTos was used alone. Overall, these findings confirm that EtOAc/DMSO (9:1) is not only a sustainable alternative to DMF, but also a highly effective medium for minimizing racemization, particularly in the coupling of challenging amino acids such as histidine. Synthesis of Model Peptides, Ile2,3-Leu-Enkephalin and Aib-ACP To further assess the efficiency of the optimized green protocol, we challenged it with the synthesis of Ile2,3-Leu-enkephalin (H-Tyr-Ile-Ile-Phe-Leu-NH2), a pentapeptide featuring two consecutive β-branched isoleucine residues at positions 2 and 3. These residues are known to complicate peptide bond formation due to increased steric hindrance, making this an ideal test case for evaluating coupling efficiency. Peptides were synthesized manually on a Rink amide resin using the EtOAc/DMSO (9:1) solvent system and EDC·MeTos as the coupling agent, either with or without OxymaPure (Figure ). Chromatographic profile of H-YIIFL-NH2 synthesized with EDC·MeTos/Oxyma and EDC·MeTos in the environmentally friendly solvent, EtOAc/DMSO. As shown in Table , both conditions yielded peptides of high purity, with the EDC·MeTos -only condition (entry 2) slightly outperforming the EDC·MeTos/Oxyma combination (entry 1), achieving a purity of 97.32% versus 94.78%, respectively. Notably, the EDC·MeTos -only approach also resulted in a lower percentage of unidentified byproducts (“Others”), suggesting a cleaner reaction profile. Although des-Phe content was marginally higher in the absence of OxymaPure, the overall performance, particularly in terms of product purity and reduced side-product formation, supports the effectiveness of EDC·MeTos alone under green solvent conditions. In addition to the improved purity profile, the isolated yield of the pentapeptide was significantly higher when EDC·MeTos was used as the sole coupling reagent, reaching 92.36%, compared with 73.12% for the EDC·MeTos/OxymaPure system. This substantial increase in yield indicates that the omission of OxymaPure not only maintains excellent coupling efficiency but also minimizes material losses during the synthesis, resulting in a more productive overall process. These results further underscore the robustness of the EtOAc/DMSO (9:1) system for challenging peptide sequences. 3HPLC Purity of H-YIIFL-NH2 Pentapeptide Synthesized with EDC·MeTos Alone and EDC·MeTos/OxymaPure in EtOAc/DMSO (9:1) Entry Coupling agent Solvent Purity (%) Des-Phe (%) Des-Tyr (%) Des-Leu (%) Others (%) 1 EtOAc/DMSO (9:1)94.780.450.930.253.59 2 EDC·MeTosEtOAc/DMSO (9:1)97.321.540.570.340.23 HPLC Purity of H-YIIFL-NH2 Pentapeptide Synthesized with EDC·MeTos Alone and EDC·MeTos/OxymaPure in EtOAc/DMSO (9:1) To further probe the general applicability of the optimized green peptide synthesis protocol, we extended our investigation to the synthesis of the Aib-ACP decapeptide (H-Val-Gln-Aib-Aib-Ile-Asp-Tyr-Ile-Asn-Gly-NH2), a longer and more challenging sequence containing Aib residues. Aib is a sterically hindered, noncoded amino acid frequently employed to induce helical structures in peptides, but its bulky, gem-dimethyl side chain poses significant challenges for efficient coupling. Thus, the Aib-Aib motif represents a particularly demanding sequence for evaluating coupling reagent performance under green conditions. In Table , two coupling strategies were compared: EDC·MeTos alone (Entry 2) and EDC·MeTos in combination with OxymaPure (Entry 1), both using the EtOAc/DMSO (9:1) solvent system. Unlike the results observed for Ile2,3-Leu-enkephalin (Table ), the addition of OxymaPure in this case had a markedly positive impact on peptide quality. Entry 1 (EDC·MeTos/Oxyma) yielded the Aib-ACP peptide with 93.19% purity (Figure ), accompanied by minimal side-product formationspecifically, 1.23% of the Aib-Aib deletion sequence and only 5.17% of other unidentified impurities. Moreover, this condition afforded an excellent isolated yield of 96.35%, confirming the high efficiency of the coupling protocol for this sterically demanding sequence. HPLC purity of Aib-ACP (RT = 2.62) synthesized with EDC·MeTos/Oxyma in EtOAc/DMSO (9:1). 4HPLC Purity of Aib-ACP-NH2 Decapeptide Synthesized with EDC·MeTos Alone and EDC·MeTos/OxymaPure in EtOAc/DMSO (9:1) Entry Coupling agent Solvent Purity (%) Des Aib (%) Des Aib-Aib (%) Others (%) 1 EDC·MeTos/OxymaEtOAc/DMSO (9:1)93.190.411.235.17 2 EDC·MeTosEtOAc/DMSO (9:1)74.805.490.6019.11 HPLC Purity of Aib-ACP-NH2 Decapeptide Synthesized with EDC·MeTos Alone and EDC·MeTos/OxymaPure in EtOAc/DMSO (9:1) In contrast, Entry 2 (EDC·MeTos alone) gave a significantly lower purity of 74.8%, along with a notable increase in deletion products, particularly 5.49% des-Aib and 19.11% of other byproducts. The isolated yield also decreased substantially to 79.47%, indicating that the absence of OxymaPure compromises both coupling efficiency and overall process productivity. On the basis of the obtained data, we selected the best-performing green protocol for the synthesis of the Aib-ACP decapeptide using a different solid support, TG S RAM resin, in order to broaden the scope of the study and further validate the robustness and general applicability of the developed methodology. As shown in Table , the use of EDC·MeTos in combination with OxymaPure afforded the target peptide with 80.54% purity, together with 3.36% of the des-Aib deletion product and 16.09% of other byproducts. Despite the moderate reduction in crude purity, the isolated yield remained remarkably high, reaching 93.21%, indicating that the coupling protocol maintains excellent synthetic efficiency on TG S RAM resin. 5HPLC Purity of Aib-ACP-NH2 Decapeptide Synthesized with EDC·MeTos/OxymaPure in EtOAc/DMSO (9:1) on TG S RAM Resin Entry Coupling agent Solvent Purity (%) Des Aib (%) Others (%) 1 EDC·MeTos/OxymaEtOAc/DMSO (9:1)80.543.3616.09 HPLC Purity of Aib-ACP-NH2 Decapeptide Synthesized with EDC·MeTos/OxymaPure in EtOAc/DMSO (9:1) on TG S RAM Resin These results confirm that the EDC·MeTos/Oxyma system in EtOAc/DMSO (9:1) remains effective also on alternative solid supports, although with a moderate decrease in efficiency compared to PS resin. The high isolated yield suggests that the protocol is robust across different resins and that the lower crude purity is mainly associated with increased byproduct formation rather than reduced coupling efficiency. These results suggest that while EDC·MeTos alone is effective for less hindered sequences (as demonstrated with Ile2,3-Leu-enkephalin), its efficiency is substantially compromised when applied to highly sterically demanding motifs like Aib-Aib. The presence of OxymaPure appears crucial in these cases, likely due to its ability to suppress side reactions and stabilize the activated species during coupling, thereby reducing epimerization and enhancing acylation efficiency (Figure ). This effect is reflected not only in the substantially higher crude purity but also in the significantly improved isolated yield (96.35% vs 79.47%), demonstrating that the EDC·MeTos/OxymaPure combination provides a more efficient and reliable synthetic process for challenging Aib-containing peptide sequences under green conditions. EDC·MeTos-mediated peptide synthesis in EtOAc/DMSO (9:1). Conclusion This study presents a comprehensive assessment of QCD as a coupling agent in solid-phase peptide synthesis using both conventional and greener solvent systems. Among the solvents tested, the EtOAc/DMSO (9:1) mixture proved to be a promising environmentally friendly alternative to DMF, offering high coupling efficiency and peptide purity. In addition to its sustainability advantages, this green solvent system also contributed to improved stereochemical integrity, as evidenced by reduced racemization levels in the synthesis of a cysteine-containing model peptide. The role of OxymaPure as a coupling additive was found to be highly dependent on the nature of the peptide sequence. While the synthesis of moderately hindered sequences such as Ile2,3-Leu-enkephalin proceeded efficiently with EDC·MeTos alone, more sterically demanding peptides like Aib-ACP required the presence of OxymaPure to achieve acceptable purity, minimize side-product formation and maximize isolated peptide yield. These results underscore the importance of context-specific optimization when applying green chemistry principles to peptide synthesis. These findings highlight that the optimal coupling strategy depends on the steric demands of the target sequence rather than on a single universally applicable protocol. Overall, EDC·MeTos-mediated coupling in EtOAc/DMSO (9:1) offers an effective and more sustainable alternative to traditional approaches, balancing environmental considerations with high synthetic performance. The consistently high isolated yields obtained under the optimized conditions further demonstrate that the proposed methodology combines synthetic efficiency with improved sustainability, making it an attractive option for green SPPS. From a practical perspective, the EtOAc/DMSO (9:1) solvent system demonstrated good compatibility with both manual and microwave-assisted SPPS protocols, without evident issues related to resin swelling, coupling kinetics, or handling. These features suggest that this solvent mixture could be potentially extended to automated peptide synthesizers and larger-scale applications. Nevertheless, further studies specifically addressing process scalability, long-term resin stability, and equipment compatibility will be required to fully validate its implementation in industrial settings. The results obtained with the peptide models investigated in this study demonstrate that EDC·MeTos-mediated coupling in EtOAc/DMSO (9:1) is a promising, more sustainable alternative for SPPS. Further studies involving a wider range of long and structurally diverse peptide sequences will be required to establish the general applicability of this methodology fully. Experimental Section Materials Nα-Fmoc-protected amino acids, Rink Amide resin, OxymaPure, Piperidine and Trifluoroacetic acid were purchased from Iris Biotech (Germany). EDC·MeTos was supplied by Luxembourg Bio Technologies. Peptide synthesis solvents, reagents, as well as CH3CN for HPLC, were reagent grade and were acquired from commercial sources and used without further purification unless otherwise noted. SPPS of Leu-Enkephalin Peptide synthesis was carried out using the solid-phase approach following the standard Fmoc strategy. The peptides were assembled manually on a Rink Amide-PS resin (100 mg, loading 0.7 mmol/g), which was initially deprotected using 20% piperidine in green solvent (EtOAc/DMSO, 9:1; NOP/DMC, 8:2; An/NOP, 75:25) or DMF (1 × 3 min +1 × 10 min) at room temperature (tr). The resin was then washed with the selected green mixture or DMF (3 × 4.5 mL) and the first protected amino acid as well as the following one were added on to the resin stepwise. Coupling reactions were achieved using Nα-Fmoc amino acids (0.25 M), EDC·MeTos (0.25 M), and OxymaPure (0.25 M) or only EDC·MeTos (0.25 M), in the selected green mixture or DMF. All coupling reactions were carried out using 0.25 M solutions of amino acids and reagents under the described conditions. After each coupling step, the Fmoc protecting group was removed as described above. Once the N-terminal Fmoc group was eliminated, peptides were cleaved from the resin using TFA/iPr3SiH/H2O (90:2.5:2.5) for 1 h at rt. The resin was separated by filtration, and the crude peptide was recovered by precipitation in cold ethyl ether, yielding a white powder, which was then lyophilized. Gradient LC-MS conditions: 0.02–5.00 min, 1–99% of solvent B, 5.00–6.00 min, return 1%, with a flow rate of 0.9 mL min–1 (Figures S1–S11). Racemization Study The H-Gly-D/L-XX-Phe-NH2 tripeptides (XX= Cys, Ser, His) were synthesized starting from Fmoc Rink amide resin (0.05 g, 0.64 mmol/g), using the new green protocol as described above (OxymaPure/EDC·MeTos 1:1, 0.25 M, or EDC·MeTos, 0.25 M). In particular, the degree of racemization was studied manually using EtOAc/DMSO (9:1) and DMF. The extent of racemization (D/L%) in the synthesis of H-Gly-XX-Phe-NH2 was assessed through HPLC analysis, as previously described. The racemization ratio was calculated as (H-Gly-D-XX-Phe-NH2 A%)/(H-Gly-L-XX-Phe-NH2 A%)×100, with the results detailed in Table . Gradient HPLC conditions: 0.01–10.00 min, 5–60% of solvent B, then 10.00–10.30 min, 90%, 10.30–11.00 min return 5%, with a flow rate of 0.4 mL min–1 (Figures S12–S26). SPPS of Ile2,3-Leu-Enkephalin and Aib-ACP MW-assisted SPPS. All syntheses were carried out under MW conditions using a Biotage Initiator + Alstra automated microwave synthesizer on a 0.1 mmol scale and a 5-fold excess of reagents. Fmoc Rink amide resin (0.05 g, 0.64 mmol/g) was used for the synthesis of enkephalin peptides and Fmoc Rink amide resin (0.05 g, 0.64 mmol/g) or TG S RAM resin (0.05 g, 0.23 mmol/g) were used for the synthesis of ACP peptides. After removal Fmoc protecting group as described above, coupling reactions were achieved using Nα-Fmoc amino acids (0.25 M), EDC·MeTos (0.25 M) and OxymaPure (0.25 M) or only EDC·MeTos (0.25 M), in EtOAc/DMSO (9:1) or DMF for 10 min at 75°, and the coupling step was repeated twice (double coupling cycle) to ensure complete reaction. All protected amino acids were added to the resin stepwise. After removal of N-terminal Fmoc group, the peptides were cleaved from the resin as described above. The crude peptides were then lyophilized to constant weight. The isolated crude peptide yield was determined by weighing the lyophilized peptides and comparing the experimental mass with the theoretical peptide mass calculated from the initial resin loading and the synthesis scale, according to the following equation: Isolatedyield(%)=(experimentalpeptidemass/theoreticalpeptidemass)×100 Finally, the crude peptides were analyzed by HPLC and LC-MS (Figures S27–S37). Supplementary Material